comparemela.com
Home
Live Updates
Orasis Pharmaceuticals Concludes Phase 3 Clinical Trials for Presbyopia Candidate : comparemela.com
Orasis Pharmaceuticals Concludes Phase 3 Clinical Trials for Presbyopia Candidate
Study enrollment complete for NEAR-1 and NEAR-2 Phase 3 Clinical TrialsHERZLIYA, Israel, March 15, 2022 /PRNewswire/ -- Orasis Pharmaceuticals, an...
Related Keywords
Japan ,
Herzliya ,
Tel Aviv ,
Israel ,
Amy Phillips ,
Elad Kedar ,
Linkedin ,
Japan Innovation Fund ,
Sequoia Capital ,
Orasis Pharmaceuticals ,
Prnewswire Orasis Pharmaceuticals ,
Chief Executive Officer ,
Visionary Ventures ,
Innovation Fund ,
Bluestem Capital ,
Lifesci Venture Partners ,
Maverick Ventures Israel ,
comparemela.com © 2020. All Rights Reserved.